Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Capital Leases (2019 - 2025)

Apyx Medical (APYX) has disclosed Capital Leases for 9 consecutive years, with $12000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Capital Leases fell 63.64% year-over-year to $12000.0, compared with a TTM value of $12000.0 through Dec 2025, down 63.64%, and an annual FY2025 reading of $12000.0, down 63.64% over the prior year.
  • Capital Leases was $12000.0 for Q4 2025 at Apyx Medical, down from $18000.0 in the prior quarter.
  • Across five years, Capital Leases topped out at $107000.0 in Q1 2021 and bottomed at $12000.0 in Q4 2025.
  • Average Capital Leases over 5 years is $48250.0, with a median of $45500.0 recorded in 2024.
  • The sharpest move saw Capital Leases tumbled 93.66% in 2021, then soared 423.08% in 2023.
  • Year by year, Capital Leases stood at $18000.0 in 2021, then soared by 305.56% to $73000.0 in 2022, then decreased by 27.4% to $53000.0 in 2023, then tumbled by 37.74% to $33000.0 in 2024, then crashed by 63.64% to $12000.0 in 2025.
  • Business Quant data shows Capital Leases for APYX at $12000.0 in Q4 2025, $18000.0 in Q3 2025, and $23000.0 in Q2 2025.